Catalyst Wire Dossier Catalyst Wire Dossier

Hansenula-Derived Pegylated Interferon Alpha-2a

pegylated interferon alpha-2a
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hansenula-Derived Pegylated Interferon Alpha-2a, covering 2014-01-06 to 2014-01-06. Get the full timeline:

Most recent: Clinical Trial Update: Hansenula-Derived Pegylated-Interferon Alpha-2a in Egyptian Children With Chronic HCV [NA]

See pricing